Abstract | BACKGROUND: A novel series of methylene-substituted DIMs (C-DIMs), namely 1,1-bis(3'-indolyl)-1-(p-substituted phenyl)methanes containing t-butyl ( DIM-C-pPhtBu) and phenyl (DIM-C-pPhC6H5) groups inhibit proliferation of invasive estrogen receptor-negative MDA-MB-231 and MDA-MB-453 human breast cancer cell lines with IC50 values between 1-5 uM. The main purpose of this study was to investigate the pathways of C-DIM-induced cell death. METHODS: The effects of the C-DIMs on apoptotic, necrotic and autophagic cell death were determined using caspase inhibitors, measurement of lactate dehydrogenase release, and several markers of autophagy including Beclin and light chain associated protein 3 expression (LC3). RESULTS: The C-DIM compounds did not induce apoptosis and only DIM-C-pPhCF3 exhibited necrotic effects. However, treatment of MDA-MB-231 and MDA-MB-453 cells with C-DIMs resulted in accumulation of LC3-II compared to LC3-I protein, a characteristic marker of autophagy, and transient transfection of green fluorescent protein-LC3 also revealed that treatment with C-DIMs induced a redistribution of LC3 to autophagosomes after C-DIM treatment. In addition, the autofluorescent drug monodansylcadaverine (MDC), a specific autophagolysosome marker, accumulated in vacuoles after C-DIM treatment, and western blot analysis of lysates from cells treated with C-DIMs showed that the Beclin 1/Bcl-2 protein ratio increased. CONCLUSION: The results suggest that C-DIM compounds may represent a new mechanism-based agent for treating drug-resistant ER-negative breast tumors through induction of autophagy.
|
Authors | Kathy Vanderlaag, Yunpeng Su, Arthur E Frankel, Robert C Burghardt, Rola Barhoumi, Gayathri Chadalapaka, Indira Jutooru, Stephen Safe |
Journal | BMC cancer
(BMC Cancer)
Vol. 10
Pg. 669
(Dec 03 2010)
ISSN: 1471-2407 [Electronic] England |
PMID | 21129193
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- 1,1-bis(3'-indolyl)-1-(4-biphenyl)methane
- 1,1-bis(3'-indolyl)-1-(4-t-butylphenyl)methane
- Amino Acid Chloromethyl Ketones
- Antineoplastic Agents
- Apoptosis Regulatory Proteins
- BECN1 protein, human
- Beclin-1
- Biomarkers, Tumor
- Caspase Inhibitors
- Cysteine Proteinase Inhibitors
- Indoles
- Macrolides
- Membrane Proteins
- Microtubule-Associated Proteins
- Proto-Oncogene Proteins c-bcl-2
- Receptors, Estrogen
- Recombinant Fusion Proteins
- benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone
- bafilomycin A1
- L-Lactate Dehydrogenase
- Caspases
|
Topics |
- Amino Acid Chloromethyl Ketones
(pharmacology)
- Animals
- Antineoplastic Agents
(pharmacology)
- Apoptosis
(drug effects)
- Apoptosis Regulatory Proteins
(metabolism)
- Autophagy
(drug effects)
- Beclin-1
- Biomarkers, Tumor
(analysis)
- Blotting, Western
- Breast Neoplasms
(chemistry, drug therapy, pathology)
- Caspase Inhibitors
- Caspases
(metabolism)
- Cell Line, Tumor
- Cell Proliferation
(drug effects)
- Cysteine Proteinase Inhibitors
(pharmacology)
- Female
- Humans
- Immunohistochemistry
- Indoles
(pharmacology)
- L-Lactate Dehydrogenase
(metabolism)
- Macrolides
(pharmacology)
- Membrane Proteins
(metabolism)
- Mice
- Mice, Inbred BALB C
- Mice, Nude
- Microtubule-Associated Proteins
(genetics, metabolism)
- Necrosis
- Proto-Oncogene Proteins c-bcl-2
(metabolism)
- Receptors, Estrogen
(analysis)
- Recombinant Fusion Proteins
(metabolism)
- Time Factors
- Transfection
- Xenograft Model Antitumor Assays
|